查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
药物警戒和药物安全软体市场规模和预测、全球和地区份额、趋势和成长机会分析报告范围：按产品、部署、企业规模、形式、功能、最终用户和地理位置
市场调查报告书
商品编码
1591394

药物警戒和药物安全软体市场规模和预测、全球和地区份额、趋势和成长机会分析报告范围：按产品、部署、企业规模、形式、功能、最终用户和地理位置

Pharmacovigilance and Drug Safety Software Market Size and Forecast, Global and Regional Share, Trend, and Growth Opportunity Analysis Report Coverage: By Offering, Deployment, Enterprise Size, Form, Functionality, End User, and Geography
出版日期: | 出版商: The Insight Partners | 英文 388 Pages | 订单完成后即时交付

价格

2023年药物警戒与药物安全软体市场规模为2.1439亿美元，预计2031年将达到3.5931亿美元；预计2023年至2031年复合年增长率为6.7%。

药物警戒和药物安全软体市场分为五个主要区域：北美、欧洲、亚太地区 (APAC)、中东和非洲 (MEA) 以及南美洲和中美洲。 2023 年，北美占据市场主导地位，其次是欧洲和亚太地区。北美的药物警戒和药物安全软体市场分为美国、加拿大和墨西哥。由于 IQVIA Oracle Corporation 等各种市场参与者的存在，北美正在见证药物警戒和药物安全软体市场的巨大增长，这些参与者不断致力于药物警戒和药物安全软体的进步。 2024 年 7 月，Oracle 公司推出了以人工智慧为基础的 Oracle Argus 平台作为 Safety One Intake 解决方案。此解决方案可帮助生命科学组织满足日益增长的监管要求并减少不良事件案例数量的增加。这个新的药物警戒平台旨在提高生产力、改善资料隐私并增强报告能力。因此，该地区市场参与者的此类产品创新正在推动该地区药物警戒和药物安全软体市场的成长。

亚太地区由印度、中国、日本、韩国、澳洲和亚太其他地区等多个成长中经济体组成。亚太地区的医疗保健产业正在经历日益数位化的发展。该地区各国政府正在采取不同的措施来加强医疗保健系统并使之数位化。例如，2023年，中国公共财政官员的医疗保健支出达到3,185亿美元。 。亚太国家不断增长的医疗保健支出在预测期内对药物警戒和药物安全软体市场的成长产生了巨大的需求。

根据企业规模，全球药物警戒和药物安全软体市场分为中小企业和大型企业。由于大公司对药物警戒软体的投资不断增加，大型企业细分市场在 2023 年的企业规模市场中占据主导地位。拥有全球业务的大型组织必须遵守多个地区的药物警戒指南。药物警戒软体有助于整合和标准化全球安全资料，确保这些组织能够在多个地区即时监控药物安全。大型组织在临床试验和上市后都会收到大量不良事件资料。药物警戒软体帮助这些组织有效地管理和分析不断增加的资料量，减少不合规或错过安全讯号的机会。随着药物警戒软体处理敏感的患者资料，大型组织正在采用具有强大资料安全性和隐私功能的软体解决方案，以确保遵守欧洲通用资料保护规范 (GDPR) 等资料保护法规。

Aris欧洲；图标公司； Syneos 健康；埃森哲； IQVIA；简柏特；认识； Paraxel国际公司；美国控股实验室公司；最大应用；克莱恩沃技术公司； Qinecsa 解决方案； AB立方体；和 Veeva Systems 是本市场研究中介绍的药物警戒和药物安全软体市场的主要参与者之一。

整体药物警戒和药物安全软体市场规模是使用主要和次要来源得出的。使用内部和外部来源进行了详尽的次要研究，以获得与药物警戒和药物安全软体市场规模相关的定性和定量资讯。该过程还有助于获得所有细分市场的市场概况和预测。此外，我们还与业界参与者进行了多次初步访谈，以验证资料并获得分析见解。该流程包括副总裁、业务开发经理、市场情报经理和国家销售经理等行业专家，以及估值专家、研究分析师和关键意见领袖等外部顾问，专门从事药物警戒和药物安全软体市场。

目录

第 1 章：简介

第 2 章：执行摘要

  • 主要见解
  • 市场吸引力

第 3 章：研究方法

  • 二次研究
  • 初步研究
    • 假设表述：
    • 宏观经济因素分析：
    • 显影基数：
    • 数据三角测量：
    • 国家级资料：

第 4 章：药物警戒与药物安全软体市场格局

  • 概述
  • PEST分析
  • 生态系分析
    • 软体/服务提供者：
    • 系统整合商：
    • 监理机构：
    • 最终用户：
    • 价值链供应商名单

第 5 章：药物警戒与药物安全软体市场 - 主要市场动态

  • 药物警戒和药物安全软体市场 - 主要市场动态
  • 市场驱动因素
    • 药物不良反应发生率上升
    • 药物警戒的全球化
    • 药物开发支出激增
  • 市场限制
    • 安装和维护成本高
  • 市场机会
    • 软体与 AI、ML 和 NLP 的集成
  • 未来趋势
    • 基于云端的药物警戒和药物安全软体：
  • 驱动因素和限制的影响：

第 6 章：药物警戒与药物安全软体市场 - 全球市场分析

  • 药物警戒与药物安全软体市场收入，2021-2031
  • 药物警戒与药物安全软体市场预测分析

第 7 章：药物警戒与药物安全软体市场分析 - 透过提供

  • 软体
  • 服务

第 8 章：药物警戒与药物安全软体市场分析 - 按部署

  • 云
  • 本地

第 9 章：药物警戒与药物安全软体市场分析 - 按企业规模

  • 大型企业
  • 中小企业

第 10 章：药物警戒与药物安全软体市场分析 - 按形式

  • 标准
  • 客製化

第 11 章：药物警戒与药物安全软体市场分析 - 按功能

  • 讯号和风险管理
  • 问题跟踪和不良事件跟踪
  • 个案管理
  • 临床安全管理与临床试验安全
  • 品质与合规性
  • 医学写作
  • 审计支援和合规培训
  • 医疗保健分析
  • 其他的

第 12 章：药物警戒与药物安全软体市场分析 - 按最终用户

  • 製药和生物技术公司
  • 合约研究组织
  • 业务流程外包 (BPO) 公司
  • 其他的

第 13 章：药物警戒与药物安全软体市场 - 地理分析

  • 北美洲
    • 美国
    • 加拿大
    • 墨西哥
  • 欧洲
    • 德国
    • 法国
    • 英国
    • 义大利
    • 西班牙
    • 俄罗斯
  • 亚太地区
    • 中国
    • 日本
    • 印度
    • 韩国
    • 澳洲
    • 亚太地区其他地区
  • 中东和非洲
    • 沙乌地阿拉伯
    • 阿拉伯聯合大公国
    • 南非
    • 中东和非洲其他地区
  • 南美洲和中美洲
    • 巴西
    • 阿根廷
    • 南美洲和中美洲其他地区

第14章：竞争格局

  • 关键参与者的热图分析
  • 公司定位与专注

第 15 章：产业格局

  • 概述
  • 市场主动性
  • 併购

第 16 章：公司简介

  • ArisGlobal LLC
  • Max Application
  • Oracle Corp
  • Veeva Systems Inc
  • IQVIA Holdings Inc
  • ICON Plc
  • Cognizant Technology Solutions Corp
  • Accenture Plc
  • Syneos Health Inc
  • Genpact Ltd.
  • AB Cube S.A.S.
  • Laboratory Corp of America Holdings
  • Parexel International Corp
  • Qinecsa Solutions
  • Clinevo Technologies

第 17 章：附录

Product Code: TIPHC00002557

The pharmacovigilance and drug safety software market size was valued at US$ 214.39 million in 2023 and is expected to reach US$ 359.31 million by 2031; it is estimated to record a CAGR of 6.7% from 2023 to 2031.

The pharmacovigilance and drug safety software market is segmented into five major regions-North America, Europe, Asia Pacific (APAC), the Middle East & Africa (MEA), and South & Central America. North America dominated the market in 2023, followed by Europe and Asia Pacific, respectively. The pharmacovigilance and drug safety software market in North America is segmented into the US, Canada, and Mexico. North America is witnessing tremendous growth in the pharmacovigilance and drug safety software market, owing to the presence of various market players such as IQVIA Oracle Corporation, who are continuously working on the advancement of pharmacovigilance and drug safety software. In July 2024, Oracle Corporation launched an AI-based Oracle Argus platform as a Safety One Intake solution. This solution helps life science organizations to meet growing regulatory requirements and to mitigate the rising volume of adverse event cases. This new pharmacovigilance platform aimed to increase productivity, improve data privacy, and enhance reporting. Thus, such product innovations by the market players in the region are fueling the growth of the pharmacovigilance and drug safety software market in the area.

Asia Pacific consists of various growing economies such as India, China, Japan, South Korea, Australia, and Rest of Asia Pacific. Asia Pacific is witnessing growing digitization in its healthcare sector. The governments of various countries in the region are taking different initiatives to enhance and digitize the healthcare system. For instance, China's healthcare expenditure of public financial officials reached US$ 318.5 billion in 2023. According to the India Brand Equity Foundation, the Indian Healthcare industry was valued at US$ 372 billion in 2023, driven by both the public and private sectors. Such rising healthcare expenditure across the Asia Pacific countries has created massive demand for the pharmacovigilance and drug safety software market growth during the forecast period.

Based on enterprise size, the global pharmacovigilance and drug safety software market is bifurcated into SMEs and large enterprises. The large enterprises segment dominated the market for enterprise size in 2023 owing to increasing investment by large companies in pharmacovigilance software. Large organizations with global operations must adhere to the pharmacovigilance guidelines of multiple regions. Pharmacovigilance software helps consolidate and standardize global safety data, ensuring that these organizations can monitor drug safety in real time across multiple geographies. Large organizations receive a high volume of adverse event data, both during clinical trials and post-marketing. Pharmacovigilance software helps these organizations manage and analyze the increasing data volume effectively, reducing the chances of noncompliance or missed safety signals. As pharmacovigilance software processes sensitive patient data, large organizations are adopting software solutions with robust data security and privacy features to ensure compliance with data protection regulations such as the General Data Protection Regulation (GDPR) in Europe.

ArisEurope; ICON plc; Syneos Health; Accenture; IQVIA; Genpact; Cognizant; Paraxel International Corporation; Laboratory Corporation of America Holdings; Max Application; Clinevo Technologies; Qinecsa Solutions; AB Cube; and Veeva Systems are among the key pharmacovigilance and drug safety software market players that are profiled in this market study.

The overall pharmacovigilance and drug safety software market size has been derived using both primary and secondary sources. Exhaustive secondary research has been conducted using internal and external sources to obtain qualitative and quantitative information related to the pharmacovigilance and drug safety software market size. The process also helps obtain an overview and forecast of the market with respect to all the market segments. Also, multiple primary interviews have been conducted with industry participants to validate the data and gain analytical insights. This process includes industry experts such as VPs, business development managers, market intelligence managers, and national sales managers, along with external consultants such as valuation experts, research analysts, and key opinion leaders, specializing in the pharmacovigilance and drug safety software market.

Table Of Contents

1. Introduction

  • 1.1 The Insight Partners Research Report Guidance
  • 1.2 Market Segmentation

2. Executive Summary

  • 2.1 Key Insights
  • 2.2 Market Attractiveness

3. Research Methodology

  • 3.1 Secondary Research
  • 3.2 Primary Research
    • 3.2.1 Hypothesis formulation:
    • 3.2.2 Macro-economic factor analysis:
    • 3.2.3 Developing base number:
    • 3.2.4 Data Triangulation:
    • 3.2.5 Country level data:

4. Pharmacovigilance and Drug Safety Software Market Landscape

  • 4.1 Overview
  • 4.2 PEST Analysis
  • 4.3 Ecosystem Analysis
    • 4.3.1 Software/Service Providers:
    • 4.3.2 System Integrators:
    • 4.3.3 Regulatory Bodies:
    • 4.3.4 End-Users:
    • 4.3.5 List of Vendors in the Value Chain

5. Pharmacovigilance and Drug Safety Software Market - Key Market Dynamics

  • 5.1 Pharmacovigilance and Drug Safety Software Market - Key Market Dynamics
  • 5.2 Market Drivers
    • 5.2.1 Rise in Incidences of Adverse Drug Reactions
    • 5.2.2 Globalization of Pharmacovigilance
    • 5.2.3 Surge in Drug Development Spending
  • 5.3 Market Restraints
    • 5.3.1 High Installation and Maintenance Costs
  • 5.4 Market Opportunities
    • 5.4.1 Integration of Software with AI, ML, and NLP
  • 5.5 Future Trends
    • 5.5.1 Cloud-Based Pharmacovigilance and Drug Safety Software:
  • 5.6 Impact of Drivers and Restraints:

6. Pharmacovigilance and Drug Safety Software Market - Global Market Analysis

  • 6.1 Pharmacovigilance and Drug Safety Software Market Revenue (US$ Million), 2021-2031
  • 6.2 Pharmacovigilance and Drug Safety Software Market Forecast Analysis

7. Pharmacovigilance and Drug Safety Software Market Analysis - by Offering

  • 7.1 Software
    • 7.1.1 Overview
    • 7.1.2 Software: Pharmacovigilance and Drug Safety Software Market - Revenue and Forecast to 2031 (US$ Million)
  • 7.2 Services
    • 7.2.1 Overview
    • 7.2.2 Services: Pharmacovigilance and Drug Safety Software Market - Revenue and Forecast to 2031 (US$ Million)

8. Pharmacovigilance and Drug Safety Software Market Analysis - by Deployment

  • 8.1 Cloud
    • 8.1.1 Overview
    • 8.1.2 Cloud: Pharmacovigilance and Drug Safety Software Market - Revenue and Forecast to 2031 (US$ Million)
  • 8.2 On Premises
    • 8.2.1 Overview
    • 8.2.2 On Premises: Pharmacovigilance and Drug Safety Software Market - Revenue and Forecast to 2031 (US$ Million)

9. Pharmacovigilance and Drug Safety Software Market Analysis - by Enterprise Size

  • 9.1 Large Enterprises
    • 9.1.1 Overview
    • 9.1.2 Large Enterprises: Pharmacovigilance and Drug Safety Software Market - Revenue and Forecast to 2031 (US$ Million)
  • 9.2 SMEs
    • 9.2.1 Overview
    • 9.2.2 SMEs: Pharmacovigilance and Drug Safety Software Market - Revenue and Forecast to 2031 (US$ Million)

10. Pharmacovigilance and Drug Safety Software Market Analysis - by Form

  • 10.1 Standard
    • 10.1.1 Overview
    • 10.1.2 Standard: Pharmacovigilance and Drug Safety Software Market - Revenue and Forecast to 2031 (US$ Million)
  • 10.2 Customized
    • 10.2.1 Overview
    • 10.2.2 Customized: Pharmacovigilance and Drug Safety Software Market - Revenue and Forecast to 2031 (US$ Million)

11. Pharmacovigilance and Drug Safety Software Market Analysis - by Functionality

  • 11.1 Signal and Risk Management
    • 11.1.1 Overview
    • 11.1.2 Signal and Risk Management: Pharmacovigilance and Drug Safety Software Market - Revenue and Forecast to 2031 (US$ Million)
  • 11.2 Issue Tracking and Adverse Event Tracking
    • 11.2.1 Overview
    • 11.2.2 Issue Tracking and Adverse Event Tracking: Pharmacovigilance and Drug Safety Software Market - Revenue and Forecast to 2031 (US$ Million)
  • 11.3 Case Management
    • 11.3.1 Overview
    • 11.3.2 Case Management: Pharmacovigilance and Drug Safety Software Market - Revenue and Forecast to 2031 (US$ Million)
  • 11.4 Clinical Safety Management and Clinical Trial Safety
    • 11.4.1 Overview
    • 11.4.2 Clinical Safety Management and Clinical Trial Safety: Pharmacovigilance and Drug Safety Software Market - Revenue and Forecast to 2031 (US$ Million)
  • 11.5 Quality and Compliance
    • 11.5.1 Overview
    • 11.5.2 Quality and Compliance: Pharmacovigilance and Drug Safety Software Market - Revenue and Forecast to 2031 (US$ Million)
  • 11.6 Medical Writing
    • 11.6.1 Overview
    • 11.6.2 Medical Writing: Pharmacovigilance and Drug Safety Software Market - Revenue and Forecast to 2031 (US$ Million)
  • 11.7 Audit Support and Training Compliance
    • 11.7.1 Overview
    • 11.7.2 Audit Support and Training Compliance: Pharmacovigilance and Drug Safety Software Market - Revenue and Forecast to 2031 (US$ Million)
  • 11.8 Healthcare Analytics
    • 11.8.1 Overview
    • 11.8.2 Healthcare Analytics: Pharmacovigilance and Drug Safety Software Market - Revenue and Forecast to 2031 (US$ Million)
  • 11.9 Others
    • 11.9.1 Overview
    • 11.9.2 Others: Pharmacovigilance and Drug Safety Software Market - Revenue and Forecast to 2031 (US$ Million)

12. Pharmacovigilance and Drug Safety Software Market Analysis - by End User

  • 12.1 Pharmaceutical and Biotechnology Companies
    • 12.1.1 Overview
    • 12.1.2 Pharmaceutical and Biotechnology Companies: Pharmacovigilance and Drug Safety Software Market - Revenue and Forecast to 2031 (US$ Million)
  • 12.2 Contract Research Organizations
    • 12.2.1 Overview
    • 12.2.2 Contract Research Organizations: Pharmacovigilance and Drug Safety Software Market - Revenue and Forecast to 2031 (US$ Million)
  • 12.3 Business Process Outsourcing (BPO) Firms
    • 12.3.1 Overview
    • 12.3.2 Business Process Outsourcing (BPO) Firms: Pharmacovigilance and Drug Safety Software Market - Revenue and Forecast to 2031 (US$ Million)
  • 12.4 Others
    • 12.4.1 Overview
    • 12.4.2 Others: Pharmacovigilance and Drug Safety Software Market - Revenue and Forecast to 2031 (US$ Million)

13. Pharmacovigilance and Drug Safety Software Market - Geographical Analysis

  • 13.1 Overview
  • 13.2 North America
    • 13.2.1 North America Pharmacovigilance and Drug Safety Software Market Overview
    • 13.2.2 North America: Pharmacovigilance and Drug Safety Software Market - Revenue and Forecast to 2031 (US$ Million)
    • 13.2.3 North America: Pharmacovigilance and Drug Safety Software Market Breakdown, by Offering
      • 13.2.3.1 North America: Pharmacovigilance and Drug Safety Software Market - Revenue and Forecast Analysis - by Offering
    • 13.2.4 North America: Pharmacovigilance and Drug Safety Software Market Breakdown, by Deployment
      • 13.2.4.1 North America: Pharmacovigilance and Drug Safety Software Market - Revenue and Forecast Analysis - by Deployment
    • 13.2.5 North America: Pharmacovigilance and Drug Safety Software Market Breakdown, by Enterprise Size
      • 13.2.5.1 North America: Pharmacovigilance and Drug Safety Software Market - Revenue and Forecast Analysis - by Enterprise Size
    • 13.2.6 North America: Pharmacovigilance and Drug Safety Software Market Breakdown, by Form
      • 13.2.6.1 North America: Pharmacovigilance and Drug Safety Software Market - Revenue and Forecast Analysis - by Form
    • 13.2.7 North America: Pharmacovigilance and Drug Safety Software Market Breakdown, by Functionality
      • 13.2.7.1 North America: Pharmacovigilance and Drug Safety Software Market - Revenue and Forecast Analysis - by Functionality
    • 13.2.8 North America: Pharmacovigilance and Drug Safety Software Market Breakdown, by End User
      • 13.2.8.1 North America: Pharmacovigilance and Drug Safety Software Market - Revenue and Forecast Analysis - by End User
    • 13.2.9 North America: Pharmacovigilance and Drug Safety Software Market - Revenue and Forecast Analysis - by Country
      • 13.2.9.1 North America: Pharmacovigilance and Drug Safety Software Market - Revenue and Forecast Analysis - by Country
      • 13.2.9.2 United States: Pharmacovigilance and Drug Safety Software Market - Revenue and Forecast to 2031 (US$ Million)
        • 13.2.9.2.1 United States: Pharmacovigilance and Drug Safety Software Market Breakdown, by Offering
        • 13.2.9.2.2 United States: Pharmacovigilance and Drug Safety Software Market Breakdown, by Deployment
        • 13.2.9.2.3 United States: Pharmacovigilance and Drug Safety Software Market Breakdown, by Enterprise Size
        • 13.2.9.2.4 United States: Pharmacovigilance and Drug Safety Software Market Breakdown, by Form
        • 13.2.9.2.5 United States: Pharmacovigilance and Drug Safety Software Market Breakdown, by Functionality
        • 13.2.9.2.6 United States: Pharmacovigilance and Drug Safety Software Market Breakdown, by End User
      • 13.2.9.3 Canada: Pharmacovigilance and Drug Safety Software Market - Revenue and Forecast to 2031 (US$ Million)
        • 13.2.9.3.1 Canada: Pharmacovigilance and Drug Safety Software Market Breakdown, by Offering
        • 13.2.9.3.2 Canada: Pharmacovigilance and Drug Safety Software Market Breakdown, by Deployment
        • 13.2.9.3.3 Canada: Pharmacovigilance and Drug Safety Software Market Breakdown, by Enterprise Size
        • 13.2.9.3.4 Canada: Pharmacovigilance and Drug Safety Software Market Breakdown, by Form
        • 13.2.9.3.5 Canada: Pharmacovigilance and Drug Safety Software Market Breakdown, by Functionality
        • 13.2.9.3.6 Canada: Pharmacovigilance and Drug Safety Software Market Breakdown, by End User
      • 13.2.9.4 Mexico: Pharmacovigilance and Drug Safety Software Market - Revenue and Forecast to 2031 (US$ Million)
        • 13.2.9.4.1 Mexico: Pharmacovigilance and Drug Safety Software Market Breakdown, by Offering
        • 13.2.9.4.2 Mexico: Pharmacovigilance and Drug Safety Software Market Breakdown, by Deployment
        • 13.2.9.4.3 Mexico: Pharmacovigilance and Drug Safety Software Market Breakdown, by Enterprise Size
        • 13.2.9.4.4 Mexico: Pharmacovigilance and Drug Safety Software Market Breakdown, by Form
        • 13.2.9.4.5 Mexico: Pharmacovigilance and Drug Safety Software Market Breakdown, by Functionality
        • 13.2.9.4.6 Mexico: Pharmacovigilance and Drug Safety Software Market Breakdown, by End User
  • 13.3 Europe
    • 13.3.1 Europe Pharmacovigilance and Drug Safety Software Market Overview
    • 13.3.2 Europe: Pharmacovigilance and Drug Safety Software Market - Revenue and Forecast to 2031 (US$ Million)
    • 13.3.3 Europe: Pharmacovigilance and Drug Safety Software Market Breakdown, by Offering
      • 13.3.3.1 Europe: Pharmacovigilance and Drug Safety Software Market - Revenue and Forecast Analysis - by Offering
    • 13.3.4 Europe: Pharmacovigilance and Drug Safety Software Market Breakdown, by Deployment
      • 13.3.4.1 Europe: Pharmacovigilance and Drug Safety Software Market - Revenue and Forecast Analysis - by Deployment
    • 13.3.5 Europe: Pharmacovigilance and Drug Safety Software Market Breakdown, by Enterprise Size
      • 13.3.5.1 Europe: Pharmacovigilance and Drug Safety Software Market - Revenue and Forecast Analysis - by Enterprise Size
    • 13.3.6 Europe: Pharmacovigilance and Drug Safety Software Market Breakdown, by Form
      • 13.3.6.1 Europe: Pharmacovigilance and Drug Safety Software Market - Revenue and Forecast Analysis - by Form
    • 13.3.7 Europe: Pharmacovigilance and Drug Safety Software Market Breakdown, by Functionality
      • 13.3.7.1 Europe: Pharmacovigilance and Drug Safety Software Market - Revenue and Forecast Analysis - by Functionality
    • 13.3.8 Europe: Pharmacovigilance and Drug Safety Software Market Breakdown, by End User
      • 13.3.8.1 Europe: Pharmacovigilance and Drug Safety Software Market - Revenue and Forecast Analysis - by End User
    • 13.3.9 Europe: Pharmacovigilance and Drug Safety Software Market - Revenue and Forecast Analysis - by Country
      • 13.3.9.1 Europe: Pharmacovigilance and Drug Safety Software Market - Revenue and Forecast Analysis - by Country
      • 13.3.9.2 Germany: Pharmacovigilance and Drug Safety Software Market - Revenue and Forecast to 2031 (US$ Million)
        • 13.3.9.2.1 Germany: Pharmacovigilance and Drug Safety Software Market Breakdown, by Offering
        • 13.3.9.2.2 Germany: Pharmacovigilance and Drug Safety Software Market Breakdown, by Deployment
        • 13.3.9.2.3 Germany: Pharmacovigilance and Drug Safety Software Market Breakdown, by Enterprise Size
        • 13.3.9.2.4 Germany: Pharmacovigilance and Drug Safety Software Market Breakdown, by Form
        • 13.3.9.2.5 Germany: Pharmacovigilance and Drug Safety Software Market Breakdown, by Functionality
        • 13.3.9.2.6 Germany: Pharmacovigilance and Drug Safety Software Market Breakdown, by End User
      • 13.3.9.3 France: Pharmacovigilance and Drug Safety Software Market - Revenue and Forecast to 2031 (US$ Million)
        • 13.3.9.3.1 France: Pharmacovigilance and Drug Safety Software Market Breakdown, by Offering
        • 13.3.9.3.2 France: Pharmacovigilance and Drug Safety Software Market Breakdown, by Deployment
        • 13.3.9.3.3 France: Pharmacovigilance and Drug Safety Software Market Breakdown, by Enterprise Size
        • 13.3.9.3.4 France: Pharmacovigilance and Drug Safety Software Market Breakdown, by Form
        • 13.3.9.3.5 France: Pharmacovigilance and Drug Safety Software Market Breakdown, by Functionality
        • 13.3.9.3.6 France: Pharmacovigilance and Drug Safety Software Market Breakdown, by End User
      • 13.3.9.4 United Kingdom: Pharmacovigilance and Drug Safety Software Market - Revenue and Forecast to 2031 (US$ Million)
        • 13.3.9.4.1 United Kingdom: Pharmacovigilance and Drug Safety Software Market Breakdown, by Offering
        • 13.3.9.4.2 United Kingdom: Pharmacovigilance and Drug Safety Software Market Breakdown, by Deployment
        • 13.3.9.4.3 United Kingdom: Pharmacovigilance and Drug Safety Software Market Breakdown, by Enterprise Size
        • 13.3.9.4.4 United Kingdom: Pharmacovigilance and Drug Safety Software Market Breakdown, by Form
        • 13.3.9.4.5 United Kingdom: Pharmacovigilance and Drug Safety Software Market Breakdown, by Functionality
        • 13.3.9.4.6 United Kingdom: Pharmacovigilance and Drug Safety Software Market Breakdown, by End User
      • 13.3.9.5 Italy: Pharmacovigilance and Drug Safety Software Market - Revenue and Forecast to 2031 (US$ Million)
        • 13.3.9.5.1 Italy: Pharmacovigilance and Drug Safety Software Market Breakdown, by Offering
        • 13.3.9.5.2 Italy: Pharmacovigilance and Drug Safety Software Market Breakdown, by Deployment
        • 13.3.9.5.3 Italy: Pharmacovigilance and Drug Safety Software Market Breakdown, by Enterprise Size
        • 13.3.9.5.4 Italy: Pharmacovigilance and Drug Safety Software Market Breakdown, by Form
        • 13.3.9.5.5 Italy: Pharmacovigilance and Drug Safety Software Market Breakdown, by Functionality
        • 13.3.9.5.6 Italy: Pharmacovigilance and Drug Safety Software Market Breakdown, by End User
      • 13.3.9.6 Spain: Pharmacovigilance and Drug Safety Software Market - Revenue and Forecast to 2031 (US$ Million)
        • 13.3.9.6.1 Spain: Pharmacovigilance and Drug Safety Software Market Breakdown, by Offering
        • 13.3.9.6.2 Spain: Pharmacovigilance and Drug Safety Software Market Breakdown, by Deployment
        • 13.3.9.6.3 Spain: Pharmacovigilance and Drug Safety Software Market Breakdown, by Enterprise Size
        • 13.3.9.6.4 Spain: Pharmacovigilance and Drug Safety Software Market Breakdown, by Form
        • 13.3.9.6.5 Spain: Pharmacovigilance and Drug Safety Software Market Breakdown, by Functionality
        • 13.3.9.6.6 Spain: Pharmacovigilance and Drug Safety Software Market Breakdown, by End User
      • 13.3.9.7 Russia: Pharmacovigilance and Drug Safety Software Market - Revenue and Forecast to 2031 (US$ Million)
        • 13.3.9.7.1 Russia: Pharmacovigilance and Drug Safety Software Market Breakdown, by Offering
        • 13.3.9.7.2 Russia: Pharmacovigilance and Drug Safety Software Market Breakdown, by Deployment
        • 13.3.9.7.3 Russia: Pharmacovigilance and Drug Safety Software Market Breakdown, by Enterprise Size
        • 13.3.9.7.4 Russia: Pharmacovigilance and Drug Safety Software Market Breakdown, by Form
        • 13.3.9.7.5 Russia: Pharmacovigilance and Drug Safety Software Market Breakdown, by Functionality
        • 13.3.9.7.6 Russia: Pharmacovigilance and Drug Safety Software Market Breakdown, by End User
  • 13.4 Asia Pacific
    • 13.4.1 Asia Pacific Pharmacovigilance and Drug Safety Software Market Overview
    • 13.4.2 Asia Pacific: Pharmacovigilance and Drug Safety Software Market - Revenue and Forecast to 2031 (US$ Million)
    • 13.4.3 Asia Pacific: Pharmacovigilance and Drug Safety Software Market Breakdown, by Offering
      • 13.4.3.1 Asia Pacific: Pharmacovigilance and Drug Safety Software Market - Revenue and Forecast Analysis - by Offering
    • 13.4.4 Asia Pacific: Pharmacovigilance and Drug Safety Software Market Breakdown, by Deployment
      • 13.4.4.1 Asia Pacific: Pharmacovigilance and Drug Safety Software Market - Revenue and Forecast Analysis - by Deployment
    • 13.4.5 Asia Pacific: Pharmacovigilance and Drug Safety Software Market Breakdown, by Enterprise Size
      • 13.4.5.1 Asia Pacific: Pharmacovigilance and Drug Safety Software Market - Revenue and Forecast Analysis - by Enterprise Size
    • 13.4.6 Asia Pacific: Pharmacovigilance and Drug Safety Software Market Breakdown, by Form
      • 13.4.6.1 Asia Pacific: Pharmacovigilance and Drug Safety Software Market - Revenue and Forecast Analysis - by Form
    • 13.4.7 Asia Pacific: Pharmacovigilance and Drug Safety Software Market Breakdown, by Functionality
      • 13.4.7.1 Asia Pacific: Pharmacovigilance and Drug Safety Software Market - Revenue and Forecast Analysis - by Functionality
    • 13.4.8 Asia Pacific: Pharmacovigilance and Drug Safety Software Market Breakdown, by End User
      • 13.4.8.1 Asia Pacific: Pharmacovigilance and Drug Safety Software Market - Revenue and Forecast Analysis - by End User
    • 13.4.9 Asia Pacific: Pharmacovigilance and Drug Safety Software Market - Revenue and Forecast Analysis - by Country
      • 13.4.9.1 Asia Pacific: Pharmacovigilance and Drug Safety Software Market - Revenue and Forecast Analysis - by Country
      • 13.4.9.2 China: Pharmacovigilance and Drug Safety Software Market - Revenue and Forecast to 2031 (US$ Million)
        • 13.4.9.2.1 China: Pharmacovigilance and Drug Safety Software Market Breakdown, by Offering
        • 13.4.9.2.2 China: Pharmacovigilance and Drug Safety Software Market Breakdown, by Deployment
        • 13.4.9.2.3 China: Pharmacovigilance and Drug Safety Software Market Breakdown, by Enterprise Size
        • 13.4.9.2.4 China: Pharmacovigilance and Drug Safety Software Market Breakdown, by Form
        • 13.4.9.2.5 China: Pharmacovigilance and Drug Safety Software Market Breakdown, by Functionality
        • 13.4.9.2.6 China: Pharmacovigilance and Drug Safety Software Market Breakdown, by End User
      • 13.4.9.3 Japan: Pharmacovigilance and Drug Safety Software Market - Revenue and Forecast to 2031 (US$ Million)
        • 13.4.9.3.1 Japan: Pharmacovigilance and Drug Safety Software Market Breakdown, by Offering
        • 13.4.9.3.2 Japan: Pharmacovigilance and Drug Safety Software Market Breakdown, by Deployment
        • 13.4.9.3.3 Japan: Pharmacovigilance and Drug Safety Software Market Breakdown, by Enterprise Size
        • 13.4.9.3.4 Japan: Pharmacovigilance and Drug Safety Software Market Breakdown, by Form
        • 13.4.9.3.5 Japan: Pharmacovigilance and Drug Safety Software Market Breakdown, by Functionality
        • 13.4.9.3.6 Japan: Pharmacovigilance and Drug Safety Software Market Breakdown, by End User
      • 13.4.9.4 India: Pharmacovigilance and Drug Safety Software Market - Revenue and Forecast to 2031 (US$ Million)
        • 13.4.9.4.1 India: Pharmacovigilance and Drug Safety Software Market Breakdown, by Offering
        • 13.4.9.4.2 India: Pharmacovigilance and Drug Safety Software Market Breakdown, by Deployment
        • 13.4.9.4.3 India: Pharmacovigilance and Drug Safety Software Market Breakdown, by Enterprise Size
        • 13.4.9.4.4 India: Pharmacovigilance and Drug Safety Software Market Breakdown, by Form
        • 13.4.9.4.5 India: Pharmacovigilance and Drug Safety Software Market Breakdown, by Functionality
        • 13.4.9.4.6 India: Pharmacovigilance and Drug Safety Software Market Breakdown, by End User
      • 13.4.9.5 South Korea: Pharmacovigilance and Drug Safety Software Market - Revenue and Forecast to 2031 (US$ Million)
        • 13.4.9.5.1 South Korea: Pharmacovigilance and Drug Safety Software Market Breakdown, by Offering
        • 13.4.9.5.2 South Korea: Pharmacovigilance and Drug Safety Software Market Breakdown, by Deployment
        • 13.4.9.5.3 South Korea: Pharmacovigilance and Drug Safety Software Market Breakdown, by Enterprise Size
        • 13.4.9.5.4 South Korea: Pharmacovigilance and Drug Safety Software Market Breakdown, by Form
        • 13.4.9.5.5 South Korea: Pharmacovigilance and Drug Safety Software Market Breakdown, by Functionality
        • 13.4.9.5.6 South Korea: Pharmacovigilance and Drug Safety Software Market Breakdown, by End User
      • 13.4.9.6 Australia: Pharmacovigilance and Drug Safety Software Market - Revenue and Forecast to 2031 (US$ Million)
        • 13.4.9.6.1 Australia: Pharmacovigilance and Drug Safety Software Market Breakdown, by Offering
        • 13.4.9.6.2 Australia: Pharmacovigilance and Drug Safety Software Market Breakdown, by Deployment
        • 13.4.9.6.3 Australia: Pharmacovigilance and Drug Safety Software Market Breakdown, by Enterprise Size
        • 13.4.9.6.4 Australia: Pharmacovigilance and Drug Safety Software Market Breakdown, by Form
        • 13.4.9.6.5 Australia: Pharmacovigilance and Drug Safety Software Market Breakdown, by Functionality
        • 13.4.9.6.6 Australia: Pharmacovigilance and Drug Safety Software Market Breakdown, by End User
      • 13.4.9.7 Rest of APAC: Pharmacovigilance and Drug Safety Software Market - Revenue and Forecast to 2031 (US$ Million)
        • 13.4.9.7.1 Rest of APAC: Pharmacovigilance and Drug Safety Software Market Breakdown, by Offering
        • 13.4.9.7.2 Rest of APAC: Pharmacovigilance and Drug Safety Software Market Breakdown, by Deployment
        • 13.4.9.7.3 Rest of APAC: Pharmacovigilance and Drug Safety Software Market Breakdown, by Enterprise Size
        • 13.4.9.7.4 Rest of APAC: Pharmacovigilance and Drug Safety Software Market Breakdown, by Form
        • 13.4.9.7.5 Rest of APAC: Pharmacovigilance and Drug Safety Software Market Breakdown, by Functionality
        • 13.4.9.7.6 Rest of APAC: Pharmacovigilance and Drug Safety Software Market Breakdown, by End User
  • 13.5 Middle East and Africa
    • 13.5.1 Middle East and Africa Pharmacovigilance and Drug Safety Software Market Overview
    • 13.5.2 Middle East and Africa: Pharmacovigilance and Drug Safety Software Market - Revenue and Forecast to 2031 (US$ Million)
    • 13.5.3 Middle East and Africa: Pharmacovigilance and Drug Safety Software Market Breakdown, by Offering
      • 13.5.3.1 Middle East and Africa: Pharmacovigilance and Drug Safety Software Market - Revenue and Forecast Analysis - by Offering
    • 13.5.4 Middle East and Africa: Pharmacovigilance and Drug Safety Software Market Breakdown, by Deployment
      • 13.5.4.1 Middle East and Africa: Pharmacovigilance and Drug Safety Software Market - Revenue and Forecast Analysis - by Deployment
    • 13.5.5 Middle East and Africa: Pharmacovigilance and Drug Safety Software Market Breakdown, by Enterprise Size
      • 13.5.5.1 Middle East and Africa: Pharmacovigilance and Drug Safety Software Market - Revenue and Forecast Analysis - by Enterprise Size
    • 13.5.6 Middle East and Africa: Pharmacovigilance and Drug Safety Software Market Breakdown, by Form
      • 13.5.6.1 Middle East and Africa: Pharmacovigilance and Drug Safety Software Market - Revenue and Forecast Analysis - by Form
    • 13.5.7 Middle East and Africa: Pharmacovigilance and Drug Safety Software Market Breakdown, by Functionality
      • 13.5.7.1 Middle East and Africa: Pharmacovigilance and Drug Safety Software Market - Revenue and Forecast Analysis - by Functionality
    • 13.5.8 Middle East and Africa: Pharmacovigilance and Drug Safety Software Market Breakdown, by End User
      • 13.5.8.1 Middle East and Africa: Pharmacovigilance and Drug Safety Software Market - Revenue and Forecast Analysis - by End User
    • 13.5.9 Middle East and Africa: Pharmacovigilance and Drug Safety Software Market - Revenue and Forecast Analysis - by Country
      • 13.5.9.1 Middle East and Africa: Pharmacovigilance and Drug Safety Software Market - Revenue and Forecast Analysis - by Country
      • 13.5.9.2 Saudi Arabia: Pharmacovigilance and Drug Safety Software Market - Revenue and Forecast to 2031 (US$ Million)
        • 13.5.9.2.1 Saudi Arabia: Pharmacovigilance and Drug Safety Software Market Breakdown, by Offering
        • 13.5.9.2.2 Saudi Arabia: Pharmacovigilance and Drug Safety Software Market Breakdown, by Deployment
        • 13.5.9.2.3 Saudi Arabia: Pharmacovigilance and Drug Safety Software Market Breakdown, by Enterprise Size
        • 13.5.9.2.4 Saudi Arabia: Pharmacovigilance and Drug Safety Software Market Breakdown, by Form
        • 13.5.9.2.5 Saudi Arabia: Pharmacovigilance and Drug Safety Software Market Breakdown, by Functionality
        • 13.5.9.2.6 Saudi Arabia: Pharmacovigilance and Drug Safety Software Market Breakdown, by End User
      • 13.5.9.3 United Arab Emirates: Pharmacovigilance and Drug Safety Software Market - Revenue and Forecast to 2031 (US$ Million)
        • 13.5.9.3.1 United Arab Emirates: Pharmacovigilance and Drug Safety Software Market Breakdown, by Offering
        • 13.5.9.3.2 United Arab Emirates: Pharmacovigilance and Drug Safety Software Market Breakdown, by Deployment
        • 13.5.9.3.3 United Arab Emirates: Pharmacovigilance and Drug Safety Software Market Breakdown, by Enterprise Size
        • 13.5.9.3.4 United Arab Emirates: Pharmacovigilance and Drug Safety Software Market Breakdown, by Form
        • 13.5.9.3.5 United Arab Emirates: Pharmacovigilance and Drug Safety Software Market Breakdown, by Functionality
        • 13.5.9.3.6 United Arab Emirates: Pharmacovigilance and Drug Safety Software Market Breakdown, by End User
      • 13.5.9.4 South Africa: Pharmacovigilance and Drug Safety Software Market - Revenue and Forecast to 2031 (US$ Million)
        • 13.5.9.4.1 South Africa: Pharmacovigilance and Drug Safety Software Market Breakdown, by Offering
        • 13.5.9.4.2 South Africa: Pharmacovigilance and Drug Safety Software Market Breakdown, by Deployment
        • 13.5.9.4.3 South Africa: Pharmacovigilance and Drug Safety Software Market Breakdown, by Enterprise Size
        • 13.5.9.4.4 South Africa: Pharmacovigilance and Drug Safety Software Market Breakdown, by Form
        • 13.5.9.4.5 South Africa: Pharmacovigilance and Drug Safety Software Market Breakdown, by Functionality
        • 13.5.9.4.6 South Africa: Pharmacovigilance and Drug Safety Software Market Breakdown, by End User
      • 13.5.9.5 Rest of Middle East and Africa: Pharmacovigilance and Drug Safety Software Market - Revenue and Forecast to 2031 (US$ Million)
        • 13.5.9.5.1 Rest of Middle East and Africa: Pharmacovigilance and Drug Safety Software Market Breakdown, by Offering
        • 13.5.9.5.2 Rest of Middle East and Africa: Pharmacovigilance and Drug Safety Software Market Breakdown, by Deployment
        • 13.5.9.5.3 Rest of Middle East and Africa: Pharmacovigilance and Drug Safety Software Market Breakdown, by Enterprise Size
        • 13.5.9.5.4 Rest of Middle East and Africa: Pharmacovigilance and Drug Safety Software Market Breakdown, by Form
        • 13.5.9.5.5 Rest of Middle East and Africa: Pharmacovigilance and Drug Safety Software Market Breakdown, by Functionality
        • 13.5.9.5.6 Rest of Middle East and Africa: Pharmacovigilance and Drug Safety Software Market Breakdown, by End User
  • 13.6 South and Central America
    • 13.6.1 South and Central America Pharmacovigilance and Drug Safety Software Market Overview
    • 13.6.2 South and Central America: Pharmacovigilance and Drug Safety Software Market - Revenue and Forecast to 2031 (US$ Million)
    • 13.6.3 South and Central America: Pharmacovigilance and Drug Safety Software Market Breakdown, by Offering
      • 13.6.3.1 South and Central America: Pharmacovigilance and Drug Safety Software Market - Revenue and Forecast Analysis - by Offering
    • 13.6.4 South and Central America: Pharmacovigilance and Drug Safety Software Market Breakdown, by Deployment
      • 13.6.4.1 South and Central America: Pharmacovigilance and Drug Safety Software Market - Revenue and Forecast Analysis - by Deployment
    • 13.6.5 South and Central America: Pharmacovigilance and Drug Safety Software Market Breakdown, by Enterprise Size
      • 13.6.5.1 South and Central America: Pharmacovigilance and Drug Safety Software Market - Revenue and Forecast Analysis - by Enterprise Size
    • 13.6.6 South and Central America: Pharmacovigilance and Drug Safety Software Market Breakdown, by Form
      • 13.6.6.1 South and Central America: Pharmacovigilance and Drug Safety Software Market - Revenue and Forecast Analysis - by Form
    • 13.6.7 South and Central America: Pharmacovigilance and Drug Safety Software Market Breakdown, by Functionality
      • 13.6.7.1 South and Central America: Pharmacovigilance and Drug Safety Software Market - Revenue and Forecast Analysis - by Functionality
    • 13.6.8 South and Central America: Pharmacovigilance and Drug Safety Software Market Breakdown, by End User
      • 13.6.8.1 South and Central America: Pharmacovigilance and Drug Safety Software Market - Revenue and Forecast Analysis - by End User
    • 13.6.9 South and Central America: Pharmacovigilance and Drug Safety Software Market - Revenue and Forecast Analysis - by Country
      • 13.6.9.1 South and Central America: Pharmacovigilance and Drug Safety Software Market - Revenue and Forecast Analysis - by Country
      • 13.6.9.2 Brazil: Pharmacovigilance and Drug Safety Software Market - Revenue and Forecast to 2031 (US$ Million)
        • 13.6.9.2.1 Brazil: Pharmacovigilance and Drug Safety Software Market Breakdown, by Offering
        • 13.6.9.2.2 Brazil: Pharmacovigilance and Drug Safety Software Market Breakdown, by Deployment
        • 13.6.9.2.3 Brazil: Pharmacovigilance and Drug Safety Software Market Breakdown, by Enterprise Size
        • 13.6.9.2.4 Brazil: Pharmacovigilance and Drug Safety Software Market Breakdown, by Form
        • 13.6.9.2.5 Brazil: Pharmacovigilance and Drug Safety Software Market Breakdown, by Functionality
        • 13.6.9.2.6 Brazil: Pharmacovigilance and Drug Safety Software Market Breakdown, by End User
      • 13.6.9.3 Argentina: Pharmacovigilance and Drug Safety Software Market - Revenue and Forecast to 2031 (US$ Million)
        • 13.6.9.3.1 Argentina: Pharmacovigilance and Drug Safety Software Market Breakdown, by Offering
        • 13.6.9.3.2 Argentina: Pharmacovigilance and Drug Safety Software Market Breakdown, by Deployment
        • 13.6.9.3.3 Argentina: Pharmacovigilance and Drug Safety Software Market Breakdown, by Enterprise Size
        • 13.6.9.3.4 Argentina: Pharmacovigilance and Drug Safety Software Market Breakdown, by Form
        • 13.6.9.3.5 Argentina: Pharmacovigilance and Drug Safety Software Market Breakdown, by Functionality
        • 13.6.9.3.6 Argentina: Pharmacovigilance and Drug Safety Software Market Breakdown, by End User
      • 13.6.9.4 Rest of South and Central America: Pharmacovigilance and Drug Safety Software Market - Revenue and Forecast to 2031 (US$ Million)
        • 13.6.9.4.1 Rest of South and Central America: Pharmacovigilance and Drug Safety Software Market Breakdown, by Offering
        • 13.6.9.4.2 Rest of South and Central America: Pharmacovigilance and Drug Safety Software Market Breakdown, by Deployment
        • 13.6.9.4.3 Rest of South and Central America: Pharmacovigilance and Drug Safety Software Market Breakdown, by Enterprise Size
        • 13.6.9.4.4 Rest of South and Central America: Pharmacovigilance and Drug Safety Software Market Breakdown, by Form
        • 13.6.9.4.5 Rest of South and Central America: Pharmacovigilance and Drug Safety Software Market Breakdown, by Functionality
        • 13.6.9.4.6 Rest of South and Central America: Pharmacovigilance and Drug Safety Software Market Breakdown, by End User

14. Competitive Landscape

  • 14.1 Heat Map Analysis by Key Players
  • 14.2 Company Positioning & Concentration

15. Industry Landscape

  • 15.1 Overview
  • 15.2 Market Initiative
  • 15.3 Merger and Acquisition

16. Company Profiles

  • 16.1 ArisGlobal LLC
    • 16.1.1 Key Facts
    • 16.1.2 Business Description
    • 16.1.3 Products and Services
    • 16.1.4 Financial Overview
    • 16.1.5 SWOT Analysis
    • 16.1.6 Key Developments
  • 16.2 Max Application
    • 16.2.1 Key Facts
    • 16.2.2 Business Description
    • 16.2.3 Products and Services
    • 16.2.4 Financial Overview
    • 16.2.5 SWOT Analysis
    • 16.2.6 Key Developments
  • 16.3 Oracle Corp
    • 16.3.1 Key Facts
    • 16.3.2 Business Description
    • 16.3.3 Products and Services
    • 16.3.4 Financial Overview
    • 16.3.5 SWOT Analysis
    • 16.3.6 Key Developments
  • 16.4 Veeva Systems Inc
    • 16.4.1 Key Facts
    • 16.4.2 Business Description
    • 16.4.3 Products and Services
    • 16.4.4 Financial Overview
    • 16.4.5 SWOT Analysis
    • 16.4.6 Key Developments
  • 16.5 IQVIA Holdings Inc
    • 16.5.1 Key Facts
    • 16.5.2 Business Description
    • 16.5.3 Products and Services
    • 16.5.4 Financial Overview
    • 16.5.5 SWOT Analysis
    • 16.5.6 Key Developments
  • 16.6 ICON Plc
    • 16.6.1 Key Facts
    • 16.6.2 Business Description
    • 16.6.3 Products and Services
    • 16.6.4 Financial Overview
    • 16.6.5 SWOT Analysis
    • 16.6.6 Key Developments
  • 16.7 Cognizant Technology Solutions Corp
    • 16.7.1 Key Facts
    • 16.7.2 Business Description
    • 16.7.3 Products and Services
    • 16.7.4 Financial Overview
    • 16.7.5 SWOT Analysis
    • 16.7.6 Key Developments
  • 16.8 Accenture Plc
    • 16.8.1 Key Facts
    • 16.8.2 Business Description
    • 16.8.3 Products and Services
    • 16.8.4 Financial Overview
    • 16.8.5 SWOT Analysis
    • 16.8.6 Key Developments
  • 16.9 Syneos Health Inc
    • 16.9.1 Key Facts
    • 16.9.2 Business Description
    • 16.9.3 Products and Services
    • 16.9.4 Financial Overview
    • 16.9.5 SWOT Analysis
    • 16.9.6 Key Developments
  • 16.10 Genpact Ltd.
    • 16.10.1 Key Facts
    • 16.10.2 Business Description
    • 16.10.3 Products and Services
    • 16.10.4 Financial Overview
    • 16.10.5 SWOT Analysis
    • 16.10.6 Key Developments
  • 16.11 AB Cube S.A.S.
    • 16.11.1 Key Facts
    • 16.11.2 Business Description
    • 16.11.3 Products and Services
    • 16.11.4 Financial Overview
    • 16.11.5 SWOT Analysis
    • 16.11.6 Key Developments
  • 16.12 Laboratory Corp of America Holdings
    • 16.12.1 Key Facts
    • 16.12.2 Business Description
    • 16.12.3 Products and Services
    • 16.12.4 Financial Overview
    • 16.12.5 SWOT Analysis
    • 16.12.6 Key Developments
  • 16.13 Parexel International Corp
    • 16.13.1 Key Facts
    • 16.13.2 Business Description
    • 16.13.3 Products and Services
    • 16.13.4 Financial Overview
    • 16.13.5 SWOT Analysis
    • 16.13.6 Key Developments
  • 16.14 Qinecsa Solutions
    • 16.14.1 Key Facts
    • 16.14.2 Business Description
    • 16.14.3 Products and Services
    • 16.14.4 Financial Overview
    • 16.14.5 SWOT Analysis
    • 16.14.6 Key Developments
  • 16.15 Clinevo Technologies
    • 16.15.1 Key Facts
    • 16.15.2 Business Descri
    • 16.15.3 Products and Services
    • 16.15.4 Financial Overview
    • 16.15.5 SWOT Analysis
    • 16.15.6 Key Developments

17. Appendix

  • 17.1 Word Index
  • 17.2 About the Insight Partners

List Of Tables

  • Table 1. Pharmacovigilance and Drug Safety Software Market Segmentation
  • Table 2. List of Vendors
  • Table 3. Pharmacovigilance and Drug Safety Software Market - Revenue and Forecast to 2031 (US$ Million)
  • Table 4. Pharmacovigilance and Drug Safety Software Market - Revenue and Forecast to 2031 (US$ Million) - by Offering
  • Table 5. Pharmacovigilance and Drug Safety Software Market - Revenue and Forecast to 2031 (US$ Million) - by Deployment
  • Table 6. Pharmacovigilance and Drug Safety Software Market - Revenue and Forecast to 2031 (US$ Million) - by Enterprise Size
  • Table 7. Pharmacovigilance and Drug Safety Software Market - Revenue and Forecast to 2031 (US$ Million) - by Form
  • Table 8. Pharmacovigilance and Drug Safety Software Market - Revenue and Forecast to 2031 (US$ Million) - by Functionality
  • Table 9. Pharmacovigilance and Drug Safety Software Market - Revenue and Forecast to 2031 (US$ Million) - by End User
  • Table 10. North America: Pharmacovigilance and Drug Safety Software Market - Revenue and Forecast to 2031(US$ Million) - by Offering
  • Table 11. North America: Pharmacovigilance and Drug Safety Software Market - Revenue and Forecast to 2031(US$ Million) - by Deployment
  • Table 12. North America: Pharmacovigilance and Drug Safety Software Market - Revenue and Forecast to 2031(US$ Million) - by Enterprise Size
  • Table 13. North America: Pharmacovigilance and Drug Safety Software Market - Revenue and Forecast to 2031(US$ Million) - by Form
  • Table 14. North America: Pharmacovigilance and Drug Safety Software Market - Revenue and Forecast to 2031(US$ Million) - by Functionality
  • Table 15. North America: Pharmacovigilance and Drug Safety Software Market - Revenue and Forecast to 2031(US$ Million) - by End User
  • Table 16. North America: Pharmacovigilance and Drug Safety Software Market - Revenue and Forecast to 2031(US$ Million) - by Country
  • Table 17. United States: Pharmacovigilance and Drug Safety Software Market - Revenue and Forecast to 2031(US$ Million) - by Offering
  • Table 18. United States: Pharmacovigilance and Drug Safety Software Market - Revenue and Forecast to 2031(US$ Million) - by Deployment
  • Table 19. United States: Pharmacovigilance and Drug Safety Software Market - Revenue and Forecast to 2031(US$ Million) - by Enterprise Size
  • Table 20. United States: Pharmacovigilance and Drug Safety Software Market - Revenue and Forecast to 2031(US$ Million) - by Form
  • Table 21. United States: Pharmacovigilance and Drug Safety Software Market - Revenue and Forecast to 2031(US$ Million) - by Functionality
  • Table 22. United States: Pharmacovigilance and Drug Safety Software Market - Revenue and Forecast to 2031(US$ Million) - by End User
  • Table 23. Canada: Pharmacovigilance and Drug Safety Software Market - Revenue and Forecast to 2031(US$ Million) - by Offering
  • Table 24. Canada: Pharmacovigilance and Drug Safety Software Market - Revenue and Forecast to 2031(US$ Million) - by Deployment
  • Table 25. Canada: Pharmacovigilance and Drug Safety Software Market - Revenue and Forecast to 2031(US$ Million) - by Enterprise Size
  • Table 26. Canada: Pharmacovigilance and Drug Safety Software Market - Revenue and Forecast to 2031(US$ Million) - by Form
  • Table 27. Canada: Pharmacovigilance and Drug Safety Software Market - Revenue and Forecast to 2031(US$ Million) - by Functionality
  • Table 28. Canada: Pharmacovigilance and Drug Safety Software Market - Revenue and Forecast to 2031(US$ Million) - by End User
  • Table 29. Mexico: Pharmacovigilance and Drug Safety Software Market - Revenue and Forecast to 2031(US$ Million) - by Offering
  • Table 30. Mexico: Pharmacovigilance and Drug Safety Software Market - Revenue and Forecast to 2031(US$ Million) - by Deployment
  • Table 31. Mexico: Pharmacovigilance and Drug Safety Software Market - Revenue and Forecast to 2031(US$ Million) - by Enterprise Size
  • Table 32. Mexico: Pharmacovigilance and Drug Safety Software Market - Revenue and Forecast to 2031(US$ Million) - by Form
  • Table 33. Mexico: Pharmacovigilance and Drug Safety Software Market - Revenue and Forecast to 2031(US$ Million) - by Functionality
  • Table 34. Mexico: Pharmacovigilance and Drug Safety Software Market - Revenue and Forecast to 2031(US$ Million) - by End User
  • Table 35. Europe: Pharmacovigilance and Drug Safety Software Market - Revenue and Forecast to 2031(US$ Million) - by Offering
  • Table 36. Europe: Pharmacovigilance and Drug Safety Software Market - Revenue and Forecast to 2031(US$ Million) - by Deployment
  • Table 37. Europe: Pharmacovigilance and Drug Safety Software Market - Revenue and Forecast to 2031(US$ Million) - by Enterprise Size
  • Table 38. Europe: Pharmacovigilance and Drug Safety Software Market - Revenue and Forecast to 2031(US$ Million) - by Form
  • Table 39. Europe: Pharmacovigilance and Drug Safety Software Market - Revenue and Forecast to 2031(US$ Million) - by Functionality
  • Table 40. Europe: Pharmacovigilance and Drug Safety Software Market - Revenue and Forecast to 2031(US$ Million) - by End User
  • Table 41. Europe: Pharmacovigilance and Drug Safety Software Market - Revenue and Forecast to 2031(US$ Million) - by Country
  • Table 42. Germany: Pharmacovigilance and Drug Safety Software Market - Revenue and Forecast to 2031(US$ Million) - by Offering
  • Table 43. Germany: Pharmacovigilance and Drug Safety Software Market - Revenue and Forecast to 2031(US$ Million) - by Deployment
  • Table 44. Germany: Pharmacovigilance and Drug Safety Software Market - Revenue and Forecast to 2031(US$ Million) - by Enterprise Size
  • Table 45. Germany: Pharmacovigilance and Drug Safety Software Market - Revenue and Forecast to 2031(US$ Million) - by Form
  • Table 46. Germany: Pharmacovigilance and Drug Safety Software Market - Revenue and Forecast to 2031(US$ Million) - by Functionality
  • Table 47. Germany: Pharmacovigilance and Drug Safety Software Market - Revenue and Forecast to 2031(US$ Million) - by End User
  • Table 48. France: Pharmacovigilance and Drug Safety Software Market - Revenue and Forecast to 2031(US$ Million) - by Offering
  • Table 49. France: Pharmacovigilance and Drug Safety Software Market - Revenue and Forecast to 2031(US$ Million) - by Deployment
  • Table 50. France: Pharmacovigilance and Drug Safety Software Market - Revenue and Forecast to 2031(US$ Million) - by Enterprise Size
  • Table 51. France: Pharmacovigilance and Drug Safety Software Market - Revenue and Forecast to 2031(US$ Million) - by Form
  • Table 52. France: Pharmacovigilance and Drug Safety Software Market - Revenue and Forecast to 2031(US$ Million) - by Functionality
  • Table 53. France: Pharmacovigilance and Drug Safety Software Market - Revenue and Forecast to 2031(US$ Million) - by End User
  • Table 54. United Kingdom: Pharmacovigilance and Drug Safety Software Market - Revenue and Forecast to 2031(US$ Million) - by Offering
  • Table 55. United Kingdom: Pharmacovigilance and Drug Safety Software Market - Revenue and Forecast to 2031(US$ Million) - by Deployment
  • Table 56. United Kingdom: Pharmacovigilance and Drug Safety Software Market - Revenue and Forecast to 2031(US$ Million) - by Enterprise Size
  • Table 57. United Kingdom: Pharmacovigilance and Drug Safety Software Market - Revenue and Forecast to 2031(US$ Million) - by Form
  • Table 58. United Kingdom: Pharmacovigilance and Drug Safety Software Market - Revenue and Forecast to 2031(US$ Million) - by Functionality
  • Table 59. United Kingdom: Pharmacovigilance and Drug Safety Software Market - Revenue and Forecast to 2031(US$ Million) - by End User
  • Table 60. Italy: Pharmacovigilance and Drug Safety Software Market - Revenue and Forecast to 2031(US$ Million) - by Offering
  • Table 61. Italy: Pharmacovigilance and Drug Safety Software Market - Revenue and Forecast to 2031(US$ Million) - by Deployment
  • Table 62. Italy: Pharmacovigilance and Drug Safety Software Market - Revenue and Forecast to 2031(US$ Million) - by Enterprise Size
  • Table 63. Italy: Pharmacovigilance and Drug Safety Software Market - Revenue and Forecast to 2031(US$ Million) - by Form
  • Table 64. Italy: Pharmacovigilance and Drug Safety Software Market - Revenue and Forecast to 2031(US$ Million) - by Functionality
  • Table 65. Italy: Pharmacovigilance and Drug Safety Software Market - Revenue and Forecast to 2031(US$ Million) - by End User
  • Table 66. Spain: Pharmacovigilance and Drug Safety Software Market - Revenue and Forecast to 2031(US$ Million) - by Offering
  • Table 67. Spain: Pharmacovigilance and Drug Safety Software Market - Revenue and Forecast to 2031(US$ Million) - by Deployment
  • Table 68. Spain: Pharmacovigilance and Drug Safety Software Market - Revenue and Forecast to 2031(US$ Million) - by Enterprise Size
  • Table 69. Spain: Pharmacovigilance and Drug Safety Software Market - Revenue and Forecast to 2031(US$ Million) - by Form
  • Table 70. Spain: Pharmacovigilance and Drug Safety Software Market - Revenue and Forecast to 2031(US$ Million) - by Functionality
  • Table 71. Spain: Pharmacovigilance and Drug Safety Software Market - Revenue and Forecast to 2031(US$ Million) - by End User
  • Table 72. Russia: Pharmacovigilance and Drug Safety Software Market - Revenue and Forecast to 2031(US$ Million) - by Offering
  • Table 73. Russia: Pharmacovigilance and Drug Safety Software Market - Revenue and Forecast to 2031(US$ Million) - by Deployment
  • Table 74. Russia: Pharmacovigilance and Drug Safety Software Market - Revenue and Forecast to 2031(US$ Million) - by Enterprise Size
  • Table 75. Russia: Pharmacovigilance and Drug Safety Software Market - Revenue and Forecast to 2031(US$ Million) - by Form
  • Table 76. Russia: Pharmacovigilance and Drug Safety Software Market - Revenue and Forecast to 2031(US$ Million) - by Functionality
  • Table 77. Russia: Pharmacovigilance and Drug Safety Software Market - Revenue and Forecast to 2031(US$ Million) - by End User
  • Table 78. Asia Pacific: Pharmacovigilance and Drug Safety Software Market - Revenue and Forecast to 2031(US$ Million) - by Offering
  • Table 79. Asia Pacific: Pharmacovigilance and Drug Safety Software Market - Revenue and Forecast to 2031(US$ Million) - by Deployment
  • Table 80. Asia Pacific: Pharmacovigilance and Drug Safety Software Market - Revenue and Forecast to 2031(US$ Million) - by Enterprise Size
  • Table 81. Asia Pacific: Pharmacovigilance and Drug Safety Software Market - Revenue and Forecast to 2031(US$ Million) - by Form
  • Table 82. Asia Pacific: Pharmacovigilance and Drug Safety Software Market - Revenue and Forecast to 2031(US$ Million) - by Functionality
  • Table 83. Asia Pacific: Pharmacovigilance and Drug Safety Software Market - Revenue and Forecast to 2031(US$ Million) - by End User
  • Table 84. Asia Pacific: Pharmacovigilance and Drug Safety Software Market - Revenue and Forecast to 2031(US$ Million) - by Country
  • Table 85. China: Pharmacovigilance and Drug Safety Software Market - Revenue and Forecast to 2031(US$ Million) - by Offering
  • Table 86. China: Pharmacovigilance and Drug Safety Software Market - Revenue and Forecast to 2031(US$ Million) - by Deployment
  • Table 87. China: Pharmacovigilance and Drug Safety Software Market - Revenue and Forecast to 2031(US$ Million) - by Enterprise Size
  • Table 88. China: Pharmacovigilance and Drug Safety Software Market - Revenue and Forecast to 2031(US$ Million) - by Form
  • Table 89. China: Pharmacovigilance and Drug Safety Software Market - Revenue and Forecast to 2031(US$ Million) - by Functionality
  • Table 90. China: Pharmacovigilance and Drug Safety Software Market - Revenue and Forecast to 2031(US$ Million) - by End User
  • Table 91. Japan: Pharmacovigilance and Drug Safety Software Market - Revenue and Forecast to 2031(US$ Million) - by Offering
  • Table 92. Japan: Pharmacovigilance and Drug Safety Software Market - Revenue and Forecast to 2031(US$ Million) - by Deployment
  • Table 93. Japan: Pharmacovigilance and Drug Safety Software Market - Revenue and Forecast to 2031(US$ Million) - by Enterprise Size
  • Table 94. Japan: Pharmacovigilance and Drug Safety Software Market - Revenue and Forecast to 2031(US$ Million) - by Form
  • Table 95. Japan: Pharmacovigilance and Drug Safety Software Market - Revenue and Forecast to 2031(US$ Million) - by Functionality
  • Table 96. Japan: Pharmacovigilance and Drug Safety Software Market - Revenue and Forecast to 2031(US$ Million) - by End User
  • Table 97. India: Pharmacovigilance and Drug Safety Software Market - Revenue and Forecast to 2031(US$ Million) - by Offering
  • Table 98. India: Pharmacovigilance and Drug Safety Software Market - Revenue and Forecast to 2031(US$ Million) - by Deployment
  • Table 99. India: Pharmacovigilance and Drug Safety Software Market - Revenue and Forecast to 2031(US$ Million) - by Enterprise Size
  • Table 100. India: Pharmacovigilance and Drug Safety Software Market - Revenue and Forecast to 2031(US$ Million) - by Form
  • Table 101. India: Pharmacovigilance and Drug Safety Software Market - Revenue and Forecast to 2031(US$ Million) - by Functionality
  • Table 102. India: Pharmacovigilance and Drug Safety Software Market - Revenue and Forecast to 2031(US$ Million) - by End User
  • Table 103. South Korea: Pharmacovigilance and Drug Safety Software Market - Revenue and Forecast to 2031(US$ Million) - by Offering
  • Table 104. South Korea: Pharmacovigilance and Drug Safety Software Market - Revenue and Forecast to 2031(US$ Million) - by Deployment
  • Table 105. South Korea: Pharmacovigilance and Drug Safety Software Market - Revenue and Forecast to 2031(US$ Million) - by Enterprise Size
  • Table 106. South Korea: Pharmacovigilance and Drug Safety Software Market - Revenue and Forecast to 2031(US$ Million) - by Form
  • Table 107. South Korea: Pharmacovigilance and Drug Safety Software Market - Revenue and Forecast to 2031(US$ Million) - by Functionality
  • Table 108. South Korea: Pharmacovigilance and Drug Safety Software Market - Revenue and Forecast to 2031(US$ Million) - by End User
  • Table 109. Australia: Pharmacovigilance and Drug Safety Software Market - Revenue and Forecast to 2031(US$ Million) - by Offering
  • Table 110. Australia: Pharmacovigilance and Drug Safety Software Market - Revenue and Forecast to 2031(US$ Million) - by Deployment
  • Table 111. Australia: Pharmacovigilance and Drug Safety Software Market - Revenue and Forecast to 2031(US$ Million) - by Enterprise Size
  • Table 112. Australia: Pharmacovigilance and Drug Safety Software Market - Revenue and Forecast to 2031(US$ Million) - by Form
  • Table 113. Australia: Pharmacovigilance and Drug Safety Software Market - Revenue and Forecast to 2031(US$ Million) - by Functionality
  • Table 114. Australia: Pharmacovigilance and Drug Safety Software Market - Revenue and Forecast to 2031(US$ Million) - by End User
  • Table 115. Rest of APAC: Pharmacovigilance and Drug Safety Software Market - Revenue and Forecast to 2031(US$ Million) - by Offering
  • Table 116. Rest of APAC: Pharmacovigilance and Drug Safety Software Market - Revenue and Forecast to 2031(US$ Million) - by Deployment
  • Table 117. Rest of APAC: Pharmacovigilance and Drug Safety Software Market - Revenue and Forecast to 2031(US$ Million) - by Enterprise Size
  • Table 118. Rest of APAC: Pharmacovigilance and Drug Safety Software Market - Revenue and Forecast to 2031(US$ Million) - by Form
  • Table 119. Rest of APAC: Pharmacovigilance and Drug Safety Software Market - Revenue and Forecast to 2031(US$ Million) - by Functionality
  • Table 120. Rest of APAC: Pharmacovigilance and Drug Safety Software Market - Revenue and Forecast to 2031(US$ Million) - by End User
  • Table 121. Middle East and Africa: Pharmacovigilance and Drug Safety Software Market - Revenue and Forecast to 2031(US$ Million) - by Offering
  • Table 122. Middle East and Africa: Pharmacovigilance and Drug Safety Software Market - Revenue and Forecast to 2031(US$ Million) - by Deployment
  • Table 123. Middle East and Africa: Pharmacovigilance and Drug Safety Software Market - Revenue and Forecast to 2031(US$ Million) - by Enterprise Size
  • Table 124. Middle East and Africa: Pharmacovigilance and Drug Safety Software Market - Revenue and Forecast to 2031(US$ Million) - by Form
  • Table 125. Middle East and Africa: Pharmacovigilance and Drug Safety Software Market - Revenue and Forecast to 2031(US$ Million) - by Functionality
  • Table 126. Middle East and Africa: Pharmacovigilance and Drug Safety Software Market - Revenue and Forecast to 2031(US$ Million) - by End User
  • Table 127. Middle East and Africa: Pharmacovigilance and Drug Safety Software Market - Revenue and Forecast to 2031(US$ Million) - by Country
  • Table 128. Saudi Arabia: Pharmacovigilance and Drug Safety Software Market - Revenue and Forecast to 2031(US$ Million) - by Offering
  • Table 129. Saudi Arabia: Pharmacovigilance and Drug Safety Software Market - Revenue and Forecast to 2031(US$ Million) - by Deployment
  • Table 130. Saudi Arabia: Pharmacovigilance and Drug Safety Software Market - Revenue and Forecast to 2031(US$ Million) - by Enterprise Size
  • Table 131. Saudi Arabia: Pharmacovigilance and Drug Safety Software Market - Revenue and Forecast to 2031(US$ Million) - by Form
  • Table 132. Saudi Arabia: Pharmacovigilance and Drug Safety Software Market - Revenue and Forecast to 2031(US$ Million) - by Functionality
  • Table 133. Saudi Arabia: Pharmacovigilance and Drug Safety Software Market - Revenue and Forecast to 2031(US$ Million) - by End User
  • Table 134. United Arab Emirates: Pharmacovigilance and Drug Safety Software Market - Revenue and Forecast to 2031(US$ Million) - by Offering
  • Table 135. United Arab Emirates: Pharmacovigilance and Drug Safety Software Market - Revenue and Forecast to 2031(US$ Million) - by Deployment
  • Table 136. United Arab Emirates: Pharmacovigilance and Drug Safety Software Market - Revenue and Forecast to 2031(US$ Million) - by Enterprise Size
  • Table 137. United Arab Emirates: Pharmacovigilance and Drug Safety Software Market - Revenue and Forecast to 2031(US$ Million) - by Form
  • Table 138. United Arab Emirates: Pharmacovigilance and Drug Safety Software Market - Revenue and Forecast to 2031(US$ Million) - by Functionality
  • Table 139. United Arab Emirates: Pharmacovigilance and Drug Safety Software Market - Revenue and Forecast to 2031(US$ Million) - by End User
  • Table 140. South Africa: Pharmacovigilance and Drug Safety Software Market - Revenue and Forecast to 2031(US$ Million) - by Offering
  • Table 141. South Africa: Pharmacovigilance and Drug Safety Software Market - Revenue and Forecast to 2031(US$ Million) - by Deployment
  • Table 142. South Africa: Pharmacovigilance and Drug Safety Software Market - Revenue and Forecast to 2031(US$ Million) - by Enterprise Size
  • Table 143. South Africa: Pharmacovigilance and Drug Safety Software Market - Revenue and Forecast to 2031(US$ Million) - by Form
  • Table 144. South Africa: Pharmacovigilance and Drug Safety Software Market - Revenue and Forecast to 2031(US$ Million) - by Functionality
  • Table 145. South Africa: Pharmacovigilance and Drug Safety Software Market - Revenue and Forecast to 2031(US$ Million) - by End User
  • Table 146. Rest of Middle East and Africa: Pharmacovigilance and Drug Safety Software Market - Revenue and Forecast to 2031(US$ Million) - by Offering
  • Table 147. Rest of Middle East and Africa: Pharmacovigilance and Drug Safety Software Market - Revenue and Forecast to 2031(US$ Million) - by Deployment
  • Table 148. Rest of Middle East and Africa: Pharmacovigilance and Drug Safety Software Market - Revenue and Forecast to 2031(US$ Million) - by Enterprise Size
  • Table 149. Rest of Middle East and Africa: Pharmacovigilance and Drug Safety Software Market - Revenue and Forecast to 2031(US$ Million) - by Form
  • Table 150. Rest of Middle East and Africa: Pharmacovigilance and Drug Safety Software Market - Revenue and Forecast to 2031(US$ Million) - by Functionality
  • Table 151. Rest of Middle East and Africa: Pharmacovigilance and Drug Safety Software Market - Revenue and Forecast to 2031(US$ Million) - by End User
  • Table 152. South and Central America: Pharmacovigilance and Drug Safety Software Market - Revenue and Forecast to 2031(US$ Million) - by Offering
  • Table 153. South and Central America: Pharmacovigilance and Drug Safety Software Market - Revenue and Forecast to 2031(US$ Million) - by Deployment
  • Table 154. South and Central America: Pharmacovigilance and Drug Safety Software Market - Revenue and Forecast to 2031(US$ Million) - by Enterprise Size
  • Table 155. South and Central America: Pharmacovigilance and Drug Safety Software Market - Revenue and Forecast to 2031(US$ Million) - by Form
  • Table 156. South and Central America: Pharmacovigilance and Drug Safety Software Market - Revenue and Forecast to 2031(US$ Million) - by Functionality
  • Table 157. South and Central America: Pharmacovigilance and Drug Safety Software Market - Revenue and Forecast to 2031(US$ Million) - by End User
  • Table 158. South and Central America: Pharmacovigilance and Drug Safety Software Market - Revenue and Forecast to 2031(US$ Million) - by Country
  • Table 159. Brazil: Pharmacovigilance and Drug Safety Software Market - Revenue and Forecast to 2031(US$ Million) - by Offering
  • Table 160. Brazil: Pharmacovigilance and Drug Safety Software Market - Revenue and Forecast to 2031(US$ Million) - by Deployment
  • Table 161. Brazil: Pharmacovigilance and Drug Safety Software Market - Revenue and Forecast to 2031(US$ Million) - by Enterprise Size
  • Table 162. Brazil: Pharmacovigilance and Drug Safety Software Market - Revenue and Forecast to 2031(US$ Million) - by Form
  • Table 163. Brazil: Pharmacovigilance and Drug Safety Software Market - Revenue and Forecast to 2031(US$ Million) - by Functionality
  • Table 164. Brazil: Pharmacovigilance and Drug Safety Software Market - Revenue and Forecast to 2031(US$ Million) - by End User
  • Table 165. Argentina: Pharmacovigilance and Drug Safety Software Market - Revenue and Forecast to 2031(US$ Million) - by Offering
  • Table 166. Argentina: Pharmacovigilance and Drug Safety Software Market - Revenue and Forecast to 2031(US$ Million) - by Deployment
  • Table 167. Argentina: Pharmacovigilance and Drug Safety Software Market - Revenue and Forecast to 2031(US$ Million) - by Enterprise Size
  • Table 168. Argentina: Pharmacovigilance and Drug Safety Software Market - Revenue and Forecast to 2031(US$ Million) - by Form
  • Table 169. Argentina: Pharmacovigilance and Drug Safety Software Market - Revenue and Forecast to 2031(US$ Million) - by Functionality
  • Table 170. Argentina: Pharmacovigilance and Drug Safety Software Market - Revenue and Forecast to 2031(US$ Million) - by End User
  • Table 171. Rest of South and Central America: Pharmacovigilance and Drug Safety Software Market - Revenue and Forecast to 2031(US$ Million) - by Offering
  • Table 172. Rest of South and Central America: Pharmacovigilance and Drug Safety Software Market - Revenue and Forecast to 2031(US$ Million) - by Deployment
  • Table 173. Rest of South and Central America: Pharmacovigilance and Drug Safety Software Market - Revenue and Forecast to 2031(US$ Million) - by Enterprise Size
  • Table 174. Rest of South and Central America: Pharmacovigilance and Drug Safety Software Market - Revenue and Forecast to 2031(US$ Million) - by Form
  • Table 175. Rest of South and Central America: Pharmacovigilance and Drug Safety Software Market - Revenue and Forecast to 2031(US$ Million) - by Functionality
  • Table 176. Rest of South and Central America: Pharmacovigilance and Drug Safety Software Market - Revenue and Forecast to 2031(US$ Million) - by End User
  • Table 177. Company Positioning & Concentration
  • Table 178. List of Abbreviation

List Of Figures

  • Figure 1. Pharmacovigilance and Drug Safety Software Market Segmentation, by Geography
  • Figure 2. PEST Analysis
  • Figure 3. Impact Analysis of Drivers and Restraints
  • Figure 4. Pharmacovigilance and Drug Safety Software Market Revenue (US$ Million), 2021-2031
  • Figure 5. Pharmacovigilance and Drug Safety Software Market Share (%) - by Offering (2023 and 2031)
  • Figure 6. Software: Pharmacovigilance and Drug Safety Software Market - Revenue and Forecast to 2031 (US$ Million)
  • Figure 7. Services: Pharmacovigilance and Drug Safety Software Market - Revenue and Forecast to 2031 (US$ Million)
  • Figure 8. Pharmacovigilance and Drug Safety Software Market Share (%) - by Deployment (2023 and 2031)
  • Figure 9. Cloud: Pharmacovigilance and Drug Safety Software Market - Revenue and Forecast to 2031 (US$ Million)
  • Figure 10. On Premises: Pharmacovigilance and Drug Safety Software Market - Revenue and Forecast to 2031 (US$ Million)
  • Figure 11. Pharmacovigilance and Drug Safety Software Market Share (%) - by Enterprise Size (2023 and 2031)
  • Figure 12. Large Enterprises: Pharmacovigilance and Drug Safety Software Market - Revenue and Forecast to 2031 (US$ Million)
  • Figure 13. SMEs: Pharmacovigilance and Drug Safety Software Market - Revenue and Forecast to 2031 (US$ Million)
  • Figure 14. Pharmacovigilance and Drug Safety Software Market Share (%) - by Form (2023 and 2031)
  • Figure 15. Standard: Pharmacovigilance and Drug Safety Software Market - Revenue and Forecast to 2031 (US$ Million)
  • Figure 16. Customized: Pharmacovigilance and Drug Safety Software Market - Revenue and Forecast to 2031 (US$ Million)
  • Figure 17. Pharmacovigilance and Drug Safety Software Market Share (%) - by Functionality (2023 and 2031)
  • Figure 18. Signal and Risk Management: Pharmacovigilance and Drug Safety Software Market - Revenue and Forecast to 2031 (US$ Million)
  • Figure 19. Issue Tracking and Adverse Event Tracking: Pharmacovigilance and Drug Safety Software Market - Revenue and Forecast to 2031 (US$ Million)
  • Figure 20. Case Management: Pharmacovigilance and Drug Safety Software Market - Revenue and Forecast to 2031 (US$ Million)
  • Figure 21. Clinical Safety Management and Clinical Trial Safety: Pharmacovigilance and Drug Safety Software Market - Revenue and Forecast to 2031 (US$ Million)
  • Figure 22. Quality and Compliance: Pharmacovigilance and Drug Safety Software Market - Revenue and Forecast to 2031 (US$ Million)
  • Figure 23. Medical Writing: Pharmacovigilance and Drug Safety Software Market - Revenue and Forecast to 2031 (US$ Million)
  • Figure 24. Audit Support and Training Compliance: Pharmacovigilance and Drug Safety Software Market - Revenue and Forecast to 2031 (US$ Million)
  • Figure 25. Healthcare Analytics: Pharmacovigilance and Drug Safety Software Market - Revenue and Forecast to 2031 (US$ Million)
  • Figure 26. Others: Pharmacovigilance and Drug Safety Software Market - Revenue and Forecast to 2031 (US$ Million)
  • Figure 27. Pharmacovigilance and Drug Safety Software Market Share (%) - by End User (2023 and 2031)
  • Figure 28. Pharmaceutical and Biotechnology Companies: Pharmacovigilance and Drug Safety Software Market - Revenue and Forecast to 2031 (US$ Million)
  • Figure 29. Contract Research Organizations: Pharmacovigilance and Drug Safety Software Market - Revenue and Forecast to 2031 (US$ Million)
  • Figure 30. Business Process Outsourcing (BPO) Firms: Pharmacovigilance and Drug Safety Software Market - Revenue and Forecast to 2031 (US$ Million)
  • Figure 31. Others: Pharmacovigilance and Drug Safety Software Market - Revenue and Forecast to 2031 (US$ Million)
  • Figure 32. Pharmacovigilance and Drug Safety Software Market Breakdown by Region, 2023 and 2031 (%)
  • Figure 33. North America: Pharmacovigilance and Drug Safety Software Market - Revenue and Forecast to 2031(US$ Million)
  • Figure 34. North America: Pharmacovigilance and Drug Safety Software Market Breakdown, by Offering (2023 and 2031)
  • Figure 35. North America: Pharmacovigilance and Drug Safety Software Market Breakdown, by Deployment (2023 and 2031)
  • Figure 36. North America: Pharmacovigilance and Drug Safety Software Market Breakdown, by Enterprise Size (2023 and 2031)
  • Figure 37. North America: Pharmacovigilance and Drug Safety Software Market Breakdown, by Form (2023 and 2031)
  • Figure 38. North America: Pharmacovigilance and Drug Safety Software Market Breakdown, by Functionality (2023 and 2031)
  • Figure 39. North America: Pharmacovigilance and Drug Safety Software Market Breakdown, by End User (2023 and 2031)
  • Figure 40. North America: Pharmacovigilance and Drug Safety Software Market Breakdown, by Key Countries, 2023 and 2031 (%)
  • Figure 41. United States: Pharmacovigilance and Drug Safety Software Market - Revenue and Forecast to 2031(US$ Million)
  • Figure 42. Canada: Pharmacovigilance and Drug Safety Software Market - Revenue and Forecast to 2031(US$ Million)
  • Figure 43. Mexico: Pharmacovigilance and Drug Safety Software Market - Revenue and Forecast to 2031(US$ Million)
  • Figure 44. Europe: Pharmacovigilance and Drug Safety Software Market - Revenue and Forecast to 2031(US$ Million)
  • Figure 45. Europe: Pharmacovigilance and Drug Safety Software Market Breakdown, by Offering (2023 and 2031)
  • Figure 46. Europe: Pharmacovigilance and Drug Safety Software Market Breakdown, by Deployment (2023 and 2031)
  • Figure 47. Europe: Pharmacovigilance and Drug Safety Software Market Breakdown, by Enterprise Size (2023 and 2031)
  • Figure 48. Europe: Pharmacovigilance and Drug Safety Software Market Breakdown, by Form (2023 and 2031)
  • Figure 49. Europe: Pharmacovigilance and Drug Safety Software Market Breakdown, by Functionality (2023 and 2031)
  • Figure 50. Europe: Pharmacovigilance and Drug Safety Software Market Breakdown, by End User (2023 and 2031)
  • Figure 51. Europe: Pharmacovigilance and Drug Safety Software Market Breakdown, by Key Countries, 2023 and 2031 (%)
  • Figure 52. Germany: Pharmacovigilance and Drug Safety Software Market - Revenue and Forecast to 2031(US$ Million)
  • Figure 53. France: Pharmacovigilance and Drug Safety Software Market - Revenue and Forecast to 2031(US$ Million)
  • Figure 54. United Kingdom: Pharmacovigilance and Drug Safety Software Market - Revenue and Forecast to 2031(US$ Million)
  • Figure 55. Italy: Pharmacovigilance and Drug Safety Software Market - Revenue and Forecast to 2031(US$ Million)
  • Figure 56. Spain: Pharmacovigilance and Drug Safety Software Market - Revenue and Forecast to 2031(US$ Million)
  • Figure 57. Russia: Pharmacovigilance and Drug Safety Software Market - Revenue and Forecast to 2031(US$ Million)
  • Figure 58. Asia Pacific: Pharmacovigilance and Drug Safety Software Market - Revenue and Forecast to 2031(US$ Million)
  • Figure 59. Asia Pacific: Pharmacovigilance and Drug Safety Software Market Breakdown, by Offering (2023 and 2031)
  • Figure 60. Asia Pacific: Pharmacovigilance and Drug Safety Software Market Breakdown, by Deployment (2023 and 2031)
  • Figure 61. Asia Pacific: Pharmacovigilance and Drug Safety Software Market Breakdown, by Enterprise Size (2023 and 2031)
  • Figure 62. Asia Pacific: Pharmacovigilance and Drug Safety Software Market Breakdown, by Form (2023 and 2031)
  • Figure 63. Asia Pacific: Pharmacovigilance and Drug Safety Software Market Breakdown, by Functionality (2023 and 2031)
  • Figure 64. Asia Pacific: Pharmacovigilance and Drug Safety Software Market Breakdown, by End User (2023 and 2031)
  • Figure 65. Asia Pacific: Pharmacovigilance and Drug Safety Software Market Breakdown, by Key Countries, 2023 and 2031 (%)
  • Figure 66. China: Pharmacovigilance and Drug Safety Software Market - Revenue and Forecast to 2031(US$ Million)
  • Figure 67. Japan: Pharmacovigilance and Drug Safety Software Market - Revenue and Forecast to 2031(US$ Million)
  • Figure 68. India: Pharmacovigilance and Drug Safety Software Market - Revenue and Forecast to 2031(US$ Million)
  • Figure 69. South Korea: Pharmacovigilance and Drug Safety Software Market - Revenue and Forecast to 2031(US$ Million)
  • Figure 70. Australia: Pharmacovigilance and Drug Safety Software Market - Revenue and Forecast to 2031(US$ Million)
  • Figure 71. Rest of APAC: Pharmacovigilance and Drug Safety Software Market - Revenue and Forecast to 2031(US$ Million)
  • Figure 72. Middle East and Africa: Pharmacovigilance and Drug Safety Software Market - Revenue and Forecast to 2031(US$ Million)
  • Figure 73. Middle East and Africa: Pharmacovigilance and Drug Safety Software Market Breakdown, by Offering (2023 and 2031)
  • Figure 74. Middle East and Africa: Pharmacovigilance and Drug Safety Software Market Breakdown, by Deployment (2023 and 2031)
  • Figure 75. Middle East and Africa: Pharmacovigilance and Drug Safety Software Market Breakdown, by Enterprise Size (2023 and 2031)
  • Figure 76. Middle East and Africa: Pharmacovigilance and Drug Safety Software Market Breakdown, by Form (2023 and 2031)
  • Figure 77. Middle East and Africa: Pharmacovigilance and Drug Safety Software Market Breakdown, by Functionality (2023 and 2031)
  • Figure 78. Middle East and Africa: Pharmacovigilance and Drug Safety Software Market Breakdown, by End User (2023 and 2031)
  • Figure 79. Middle East and Africa: Pharmacovigilance and Drug Safety Software Market Breakdown, by Key Countries, 2023 and 2031 (%)
  • Figure 80. Saudi Arabia: Pharmacovigilance and Drug Safety Software Market - Revenue and Forecast to 2031(US$ Million)
  • Figure 81. United Arab Emirates: Pharmacovigilance and Drug Safety Software Market - Revenue and Forecast to 2031(US$ Million)
  • Figure 82. South Africa: Pharmacovigilance and Drug Safety Software Market - Revenue and Forecast to 2031(US$ Million)
  • Figure 83. Rest of Middle East and Africa: Pharmacovigilance and Drug Safety Software Market - Revenue and Forecast to 2031(US$ Million)
  • Figure 84. South and Central America: Pharmacovigilance and Drug Safety Software Market - Revenue and Forecast to 2031(US$ Million)
  • Figure 85. South and Central America: Pharmacovigilance and Drug Safety Software Market Breakdown, by Offering (2023 and 2031)
  • Figure 86. South and Central America: Pharmacovigilance and Drug Safety Software Market Breakdown, by Deployment (2023 and 2031)
  • Figure 87. South and Central America: Pharmacovigilance and Drug Safety Software Market Breakdown, by Enterprise Size (2023 and 2031)
  • Figure 88. South and Central America: Pharmacovigilance and Drug Safety Software Market Breakdown, by Form (2023 and 2031)
  • Figure 89. South and Central America: Pharmacovigilance and Drug Safety Software Market Breakdown, by Functionality (2023 and 2031)
  • Figure 90. South and Central America: Pharmacovigilance and Drug Safety Software Market Breakdown, by End User (2023 and 2031)
  • Figure 91. South and Central America: Pharmacovigilance and Drug Safety Software Market Breakdown, by Key Countries, 2023 and 2031 (%)
  • Figure 92. Brazil: Pharmacovigilance and Drug Safety Software Market - Revenue and Forecast to 2031(US$ Million)
  • Figure 93. Argentina: Pharmacovigilance and Drug Safety Software Market - Revenue and Forecast to 2031(US$ Million)
  • Figure 94. Rest of South and Central America: Pharmacovigilance and Drug Safety Software Market - Revenue and Forecast to 2031(US$ Million)
  • Figure 95. Heat Map Analysis by Key Players